According to a research report published this morning, Morgan Stanley has decreased Itron's ITRI PT from $52 to $51.
In the report, Morgan Stanley commented, "Itron handily beat top-line expectations but higher opex drives a 2% cut to our 2012 EPS. On the call, mgmt clarified that 1Q12 opex should not be annualized. As such, orders were resilient and end-market momentum is intact – maintain OW."
Itron closed yesterday at $44.73.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in